569
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluations

Valganciclovir for the prevention and treatment of CMV in solid organ transplant recipients

, PhD, , MD PhD & , MD PhD
Pages 1159-1166 | Published online: 03 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marie A Yu & Jeong M Park. (2013) Valganciclovir: therapeutic role in pediatric solid organ transplant recipients . Expert Opinion on Pharmacotherapy 14:6, pages 807-815.
Read now

Articles from other publishers (10)

V. Ganesh, K. Sahini, P. Poorna Basuri & C.N. Nalini. (2022) Review of analytical and bioanalytical techniques for the determination of first-line anticytomegalovirus drugs. Chinese Journal of Analytical Chemistry 50:8, pages 100123.
Crossref
Maud Maillard, Li Gong, Rina Nishii, Jun J. Yang, Michelle Whirl-Carrillo & Teri E. Klein. (2022) PharmGKB summary: acyclovir/ganciclovir pathway. Pharmacogenetics and Genomics 32:5, pages 201-208.
Crossref
Giovanni Autore, Luca Bernardi, Serafina Perrone & Susanna Esposito. (2021) Update on Viral Infections Involving the Central Nervous System in Pediatric Patients. Children 8:9, pages 782.
Crossref
Małgorzata Mizerska-Wasiak, Maria Winiarska, Karolina Nogal, Karolina Cichoń-Kawa, Małgorzata Pańczyk-Tomaszewska & Jadwiga Małdyk. (2021) IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis. Pediatric Reports 13:3, pages 416-420.
Crossref
Sandesh Parajuli, Margaret Jorgenson, Ross O. Meyers, Arjang Djamali & Jacques Galipeau. (2021) Role of Virus-Specific T Cell Therapy for Cytomegalovirus and BK Infections in Kidney Transplant Recipients. Kidney360 2:5, pages 905-915.
Crossref
Şule Gökçe. 2020. Human Herpesvirus Infection - Biological Features, Transmission, Symptoms, Diagnosis and Treatment. Human Herpesvirus Infection - Biological Features, Transmission, Symptoms, Diagnosis and Treatment.
A. Åsberg, A. Bjerre & M. Neely. (2013) New algorithm for valganciclovir dosing in pediatric solid organ transplant recipients. Pediatric Transplantation 18:1, pages 103-111.
Crossref
Julian Torre-Cisneros, M. Carmen Fariñas, Juan José Castón, José María Aguado, Sara Cantisán, Jordi Carratalá, Carlos Cervera, José Miguel Cisneros, Elisa Cordero, Maria G. Crespo-Leiro, Jesús Fortún, Esteban Frauca, Joan Gavaldá, Salvador Gil-Vernet, Mercé Gurguí, Oscar Len, Carlos Lumbreras, María Ángeles Marcos, Pilar Martín-Dávila, Victor Monforte, Miguel Montejo, Asunción Moreno, Patricia Muñoz, David Navarro, Albert Pahissa, José Luis Pérez, Alberto Rodriguez-Bernot, José Rumbao, Rafael San Juan, Francisco Santos, Evaristo Varo & Felipe Zurbano. (2011) GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients. Enfermedades Infecciosas y Microbiología Clínica 29:10, pages 735-758.
Crossref
Francisco Santos Luna & Jordi Carratalà. (2011) Tratamiento de la enfermedad por citomegalovirus. Enfermedades Infecciosas y Microbiología Clínica 29, pages 65-69.
Crossref
Horst Welker, Mahdi Farhan, Atul Humar & Carla Washington. (2010) Ganciclovir Pharmacokinetic Parameters Do Not Change When Extending Valganciclovir Cytomegalovirus Prophylaxis From 100 to 200 Days. Transplantation 90:12, pages 1414-1419.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.